Top Markets
#1 Siren Siren +38.40%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#3 RedStone RedStone +20.62%
#4 Cysic Cysic +16.54%
#5 Ocean Protocol Ocean Protocol +16.20%
#6 Arowana Arowana +15.22%
#7 KUB Coin KUB Coin +13.95%
#8 Perle Perle +13.86%
#9 Verus Coin Verus Coin +13.51%
#10 Quack AI Quack AI +9.51%
Coin of the day
Siren Siren
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Joyzyme Group Limited Joyzyme Group Limited

Joyzyme Group Limited

8622
Classement en actions #32056
Huakang Biomedical Holdings Company Limited operates as an investment holding... Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
Prix de l'action
$0.02187539
Capitalisation boursière
$11.28M
Changement (1 jour)
0.00%
Changement (1 an)
-54.99%
Pays
HK
Échange Joyzyme Group Limited (8622)

Catégorie

Healthcare
Bénéfices pour Joyzyme Group Limited (8622)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Joyzyme Group Limited, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Joyzyme Group Limited de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN